We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
SANDRENA Orion Pharma (AUS) Pty Limited
Product name
SANDRENA
Sponsor
Accepted date
Oct-2025
Active ingredients
estradiol hemihydrate
Proposed indication
Sandrena (estradiol) is proposed for the prevention of bone loss (osteoporosis) in women who have gone through menopause and are at high risk of breaking bones. It is intended for those who cannot use, or do not tolerate, other approved medicines for preventing osteoporosis.
Application type
C (new indication)
Publication date
Oct-2025